骨生検の世界市場

骨生検の世界市場は2030年までに8億6,300万米ドルに達する見込み

2024年に6億9,590万米ドルと推定される骨生検の世界市場は、2030年には8億6,300万米ドルに達し、分析期間2024～2030年のCAGRは3.7%で成長すると予測されます。本レポートで分析したセグメントの1つであるニードルバイオプシーは、CAGR 2.9%を記録し、分析期間終了時には5億3,140万米ドルに達すると予測されます。オープン生検セグメントの成長率は、分析期間中CAGR 4.9％と推定されます。

米国市場は1億8,960万米ドルと推定、中国はCAGR6.6%で成長予測

米国の骨生検市場は、2024年に1億8,960万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億7,180万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と2.8%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の骨生検市場- 主要動向と促進要因のまとめ

骨生検が現代の診断医療で重要性を増している理由とは？

骨生検は、特に原因不明の骨病変、持続的な骨痛、悪性腫瘍の疑いなどの評価において、診断医学の要となりつつあります。骨がん、転移性腫瘍、骨髄炎などの感染症、骨粗鬆症やパジェット病などの代謝性骨疾患などの病態を特定する上で重要な役割を果たしています。構造的な洞察を提供する画像診断技術とは対照的に、骨生検では組織を直接採取することができるため、病理組織学的および分子生物学的解析による確定診断が可能です。がん、特に骨に転移することの多い転移性がん（乳がん、前立腺がん、肺がんなど）の増加により、骨生検による正確で早期の診断の必要性が最も高まっています。生検は、悪性腫瘍の存在を確認するだけでなく、腫瘍の起源、悪性度、潜在的な治療効果の判定にも役立ちます。コアニードルや細針吸引法などの針を用いた生検法の進歩により、この手技は侵襲性が低くなり、臨床の場においてより利用しやすくなりました。さらに、CTやMRIガイド下生検のような画像ガイド下手技が利用できるようになったことで、手技の精度が向上し、手技のリスクが減少しました。個別化医療がより顕著になるにつれ、骨生検はゲノム解析やバイオマーカー解析に必要な組織を採取するためにも不可欠であり、診断的価値をさらに高めています。早期介入、標的治療、費用対効果の高い診断にますます重点を置くヘルスケアシステムにより、骨生検は腫瘍学、整形外科、感染症管理にわたって不可欠なツールとして台頭しています。

技術の進歩は、骨生検の手技にどのような革命をもたらしているのでしょうか？

技術革新は、骨生検手技の安全性、正確性、臨床的有用性を大幅に向上させています。従来の開腹手術による生検は、複雑な症例にはまだ使用されていますが、回復時間が短く、合併症のリスクが低く、患者の快適性を高める低侵襲の経皮的手技に急速に取って代わられつつあります。CT、X線透視、MRIなどの画像診断機器は、病変をリアルタイムで可視化し、針を正確に留置することを可能にする高度な生検針と併用されています。この組み合わせは、高品質のサンプル採取を保証すると同時に、周辺組織へのダメージを最小限に抑えます。ロボット工学とナビゲーション支援技術が骨生検のワークフローに組み込まれ始めており、ミリメートル以下の精度を提供し、脊椎や骨盤のような解剖学的に困難な場所での生検を可能にしています。さらに、3D画像やAR（拡張現実）プラットフォームは、術前計画やリアルタイムのガイダンスのために検討されています。検査室側では、デジタル病理学、次世代シークエンシング（NGS）、分子診断学が検体の分析方法を変え、遺伝子変異、分子標的、予測バイオマーカーの同定を可能にしています。これらの技術革新により、臨床医は、特にがん治療において、高度に個別化された治療戦略を開発することができます。電子カルテ（EHR）と診断プラットフォームの統合により、シームレスなデータ転送と多職種連携が保証されます。その結果、診断手順が効率化されるだけでなく、情報量も増え、疾患の病態や進行に関する深い洞察が得られるようになりました。このようなテクノロジーと診断学の融合により、骨生検は、現代の治療方針を決定するための重要な情報を提供する高精度の検査法として位置づけられています。

疾患疫学とヘルスケア慣行の変化は、骨生検市場にどのような影響を与えていますか？

疾患パターンの変化とヘルスケア提供モデルの進化が、市場情勢の変化をもたらしています。世界のがん罹患率の増加、特に高齢化社会におけるがん罹患率の増加は、骨病変を評価できる診断手技の需要を促進する主な要因です。同様に、先進経済諸国および新興経済諸国における慢性骨感染症や代謝性疾患の増加が、新たな需要チャネルを生み出しています。例えば、糖尿病患者は足の感染症や骨髄炎にかかりやすく、正確な診断と的確な治療を必要とすることが多いです。さらに、外来患者や外来診療の推進により、最小限のリソースで即日臨床が可能な低侵襲の骨生検技術の使用が促進されています。この移行は、診断の質を落とすことなく、ヘルスケアコストを削減し、患者のスループットを向上させる。これと並行して、特に骨に関連する悪性腫瘍や全身疾患による骨格合併症のリスクが高い人に対する早期発見とスクリーニングが重視されるようになってきています。国の保健機関やがん擁護団体は、早期生検が生存率や治療効果を向上させるという利点について認識を広めています。新興国市場では、診断インフラ、臨床医のトレーニング、専門医療への患者のアクセスなどが徐々に改善され、骨生検市場に新たな成長機会がもたらされています。さらに、公的医療機関と民間の診断ラボとの連携により、紹介システムが改善され、診断範囲が広がっています。骨生検が日常的な診断医療や慢性疾患管理に深く統合されるように、これらの要因が集約されつつあります。

骨生検世界市場の成長を促進する主な要因は？

世界の骨生検市場の成長は、臨床的要因、技術的要因、人口統計的要因、経済的要因の相乗効果によってもたらされます。最も重要な促進要因の1つは、がん、特に進行期の悪性腫瘍に伴う骨転移の世界の負担増です。正確で組織学的に確定された診断に対する需要が高まるにつれ、効率的で低侵襲な生検手技に対するニーズも高まっています。画像ガイド下手技の広範な採用や技術的に進歩したヘルスケア施設の普及により、骨生検は以前にも増して安全で、迅速で、利用しやすいものとなっています。病理学的サービスの向上と分子診断学の統合も、特に腫瘍学において、個別化された治療計画のために骨生検を利用する臨床医を後押ししています。高齢者は骨脆弱性、溶骨性病変、代謝性骨疾患に罹患しやすく、組織ベースの診断が必要となるためです。特にアジア太平洋、ラテンアメリカ、中東では、筋骨格の健康に対する意識の高まりとヘルスケアインフラへの政府投資が、骨生検を含む診断サービスの拡大を支えています。バリュー・ベース・ケアの台頭と早期介入への注目の高まりは、誤診や治療の遅れを防ぐ費用対効果の高いツールとして、ヘルスケアプロバイダーに骨生検を採用する動機付けとなっています。さらに、医療機器メーカーは生検針のデザイン、画像の互換性、サンプルの保存において技術革新を進めており、より正確で信頼性の高い手技を可能にしています。患者の期待がより低侵襲、より迅速、より個別化された治療へと進化するにつれ、骨生検の需要は着実に伸びると予想され、現代の診断と疾病管理に不可欠な要素となっています。

セグメント

タイプ（針生検、開腹生検）、ガイドタイプ（MRIガイド、CTガイド）、エンドユーザー（病院・診療所エンドユーザー、外来手術センターエンドユーザー、その他エンドユーザー）

調査対象企業の例（合計 36注目）

• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company（BD）
• BIOPSYBELL Srl
• Cardinal Health, Inc.
• Cook Medical LLC
• Devicor Medical Products, Inc.
• DiaSorin S.p.A.
• Hologic, Inc.
• IZI Medical Products
• Kimal PLC
• Laurane Medical LLC
• Meditech Devices Pvt. Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• Moller Medical GmbH
• Olympus Corporation
• Remington Medical, Inc.
• SOMATEX Medical Technologies GmbH
• Stryker Corporation

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中のドメイン専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Bone Biopsy Market to Reach US$863.0 Million by 2030

The global market for Bone Biopsy estimated at US$695.9 Million in the year 2024, is expected to reach US$863.0 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Needle Biopsy, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$531.4 Million by the end of the analysis period. Growth in the Open Biopsy segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$189.6 Million While China is Forecast to Grow at 6.6% CAGR

The Bone Biopsy market in the U.S. is estimated at US$189.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$171.8 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Bone Biopsy Market - Key Trends & Drivers Summarized

Why Is Bone Biopsy Gaining Critical Importance in Modern Diagnostic Medicine?

Bone biopsy is increasingly becoming a cornerstone of diagnostic medicine, particularly in the evaluation of unexplained bone lesions, persistent bone pain, or suspected malignancies. It plays a vital role in identifying conditions such as bone cancer, metastatic tumors, infections like osteomyelitis, and metabolic bone disorders such as osteoporosis and Paget’s disease. In contrast to imaging techniques that provide structural insights, a bone biopsy allows for direct tissue sampling, offering a definitive diagnosis through histopathological and molecular analysis. With the growing prevalence of cancer, especially metastatic cancers that frequently spread to the bones (e.g., breast, prostate, and lung cancer), the need for accurate and early diagnosis via bone biopsy has become paramount. It not only helps in confirming the presence of malignancy but also in determining the origin, grade, and potential treatment responses of the tumor. Advances in needle-based biopsy methods, including core needle and fine needle aspiration, have made the procedure less invasive and more accessible across clinical settings. Furthermore, the increasing availability of image-guided techniques such as CT and MRI-guided biopsies has improved precision and reduced procedural risks. As personalized medicine becomes more prominent, bone biopsies are also essential for collecting tissue needed for genomic and biomarker analysis, further enhancing their diagnostic value. With healthcare systems increasingly focusing on early intervention, targeted therapy, and cost-effective diagnostics, bone biopsy is emerging as an essential tool across oncology, orthopedics, and infectious disease management.

How Are Technological Advancements Revolutionizing Bone Biopsy Procedures?

Technological innovations are significantly enhancing the safety, accuracy, and clinical utility of bone biopsy procedures. Traditional open surgical biopsies, while still in use for complex cases, are rapidly being replaced by minimally invasive percutaneous techniques that offer shorter recovery times, lower risk of complications, and higher patient comfort. Imaging modalities such as CT, fluoroscopy, and MRI are being used in tandem with advanced biopsy needles to allow for real-time visualization of the lesion and precise needle placement. This combination minimizes damage to surrounding tissues while ensuring high-quality sample collection. Robotics and navigation-assisted technologies are beginning to be integrated into bone biopsy workflows, offering sub-millimeter accuracy and enabling biopsies in anatomically challenging locations, such as the spine or pelvis. Additionally, 3D imaging and augmented reality platforms are being explored for pre-procedural planning and real-time guidance. On the laboratory side, digital pathology, next-generation sequencing (NGS), and molecular diagnostics are transforming how bone biopsy specimens are analyzed, allowing for the identification of genetic mutations, molecular targets, and predictive biomarkers. These innovations enable clinicians to develop highly individualized treatment strategies, especially in cancer care. The integration of electronic health records (EHRs) with diagnostic platforms ensures seamless data transfer and multidisciplinary collaboration. As a result, the procedure is not only becoming more efficient but also more informative, providing deeper insights into disease pathology and progression. This fusion of technology and diagnostics is positioning bone biopsy as a high-precision procedure that delivers critical information to guide modern therapeutic decisions.

How Are Shifts in Disease Epidemiology and Healthcare Practices Impacting the Bone Biopsy Market?

Changing disease patterns and evolving healthcare delivery models are reshaping the landscape of the bone biopsy market. The global increase in cancer incidence, especially among aging populations, is a primary factor driving the demand for diagnostic procedures capable of evaluating bone involvement. Similarly, the rise of chronic bone infections and metabolic disorders in both developed and emerging economies is creating new demand channels. Patients with diabetes, for instance, are more prone to foot infections and osteomyelitis, conditions that often require bone biopsy for accurate diagnosis and targeted treatment. In addition, the push toward outpatient and ambulatory care is facilitating the use of minimally invasive bone biopsy techniques that can be performed in same-day clinical settings with minimal resources. This transition reduces healthcare costs and improves patient throughput without compromising diagnostic quality. In parallel, there is an increasing emphasis on early detection and screening, particularly for individuals at high risk of bone-related malignancies or skeletal complications from systemic diseases. National health agencies and cancer advocacy groups are promoting awareness about the benefits of early biopsy in improving survival and treatment efficacy. In developing regions, gradual improvements in diagnostic infrastructure, clinician training, and patient access to specialty care are opening up new growth opportunities for the bone biopsy market. Additionally, collaborations between public health institutions and private diagnostic labs are leading to improved referral systems and broader diagnostic reach. All of these factors are converging to integrate bone biopsy more deeply into the fabric of routine diagnostic medicine and chronic disease management.

What Key Factors Are Driving the Growth of the Global Bone Biopsy Market?

The growth in the global bone biopsy market is driven by a synergy of clinical, technological, demographic, and economic factors. One of the most significant drivers is the rising global burden of cancer, especially bone metastases associated with advanced-stage malignancies. As the demand for precise, histologically confirmed diagnoses increases, so does the need for efficient and minimally invasive biopsy procedures. The widespread adoption of image-guided techniques and the proliferation of technologically advanced healthcare facilities are making bone biopsy safer, faster, and more accessible than ever before. Improvements in pathology services and the integration of molecular diagnostics are also encouraging clinicians to rely on bone biopsy for personalized treatment planning, particularly in oncology. The global aging population is another key driver, as older adults are more prone to bone fragility, osteolytic lesions, and metabolic bone diseases that require tissue-based diagnosis. Growing awareness of musculoskeletal health and government investments in healthcare infrastructure-especially in Asia-Pacific, Latin America, and the Middle East-are supporting the expansion of diagnostic services, including bone biopsies. The rise of value-based care and a stronger focus on early intervention have incentivized healthcare providers to adopt bone biopsy as a cost-effective tool for preventing misdiagnoses and treatment delays. Furthermore, medical device manufacturers are innovating in biopsy needle design, imaging compatibility, and sample preservation, enabling more precise and reliable procedures. As patient expectations evolve toward less invasive, faster, and more personalized care, the demand for bone biopsy is expected to grow steadily, making it a critical component of modern diagnostics and disease management.

SCOPE OF STUDY:

The report analyzes the Bone Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Needle Biopsy, Open Biopsy); Guide Type (MRI-Guided, CT-Guided); End-Use (Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• BIOPSYBELL Srl
• Cardinal Health, Inc.
• Cook Medical LLC
• Devicor Medical Products, Inc.
• DiaSorin S.p.A.
• Hologic, Inc.
• IZI Medical Products
• Kimal PLC
• Laurane Medical LLC
• Meditech Devices Pvt. Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• Moller Medical GmbH
• Olympus Corporation
• Remington Medical, Inc.
• SOMATEX Medical Technologies GmbH
• Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Bone Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Bone Disorders and Cancers Throws the Spotlight on Bone Biopsy as a Diagnostic Standard
  • Increased Emphasis on Early Detection Spurs Growth in Biopsy Procedures for Suspected Bone Lesions
  • Here's How Advanced Imaging Integration Is Enhancing Accuracy and Safety of Image-Guided Bone Biopsies
  • Growth in Oncology and Orthopedic Diagnostics Expands Clinical Use of Bone Biopsy Across Healthcare Settings
  • Expansion of Minimally Invasive Procedures Strengthens the Business Case for Needle-Based Core Biopsy Techniques
  • Improved Pathology and Biomarker Analysis Tools Drive Adoption of Bone Biopsy for Personalized Treatment Planning
  • Here's the Story: How Bone Biopsy Is Becoming Central to Diagnosing Rare Bone Tumors and Metabolic Bone Disease
  • Global Growth in Cancer Screening Programs Increases Procedure Volume in Hospital and Diagnostic Labs
  • Rising Awareness Among Clinicians About Bone Marrow vs. Bone Biopsy Indications Enhances Procedural Accuracy
  • Innovation in Biopsy Needle Design and Radiolucent Markers Supports Procedural Efficiency and Patient Comfort
  • Increased Availability of CT and MRI Imaging in Emerging Markets Fuels Adoption of Image-Guided Biopsies
  • Integration with Molecular Testing Expands Role of Bone Biopsy in Precision Oncology and Targeted Therapies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Bone Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Bone Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Needle Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Needle Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Needle Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Open Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Open Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Open Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for MRI-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for MRI-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for MRI-Guided by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for CT-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for CT-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for CT-Guided by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospital & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: China 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Bone Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: France 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Germany 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Italy 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: UK 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Spain 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Russia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Bone Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Australia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: India 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: South Korea 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Bone Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Latin America 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Argentina 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Brazil 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Mexico 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Bone Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Middle East 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Iran 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Israel 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: UAE 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Africa 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION